The UK Supreme Court’s approach in Actavis v Eli Lilly brought the country closer to harmonisation with other European nations, but there’s still not a wholly consistent view on the doctrine of equivalents across Europe.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
LSPN Europe 2017, Actavis v Eli Lilly, harmonisation, EU, Finnegan, Henderson, Farabow, Garrett & Dunner, direct infringement, Unified Patent Court , UPC